Rural Health
Resources by Topic: Substance use and misuse
PROSPER Delivery of Universal Preventive Interventions with Young Adolescents: Long-term Effects on Emerging Adult Substance Misuse and Associated Risk Behaviors
Presents a study on the long term effects of substance abuse in young adults and the effectiveness of PROSPER prevention interventions for young adolescents. Features participants from 28 rural communities in Pennsylvania and Iowa.
Author(s): Richard Spoth, Cleve Redmond, Chungyeol Shin, et al.
Citation: Psychological Medicine, 47(3), 2246-2259
Date: 10/2017
Type: Document
view details
Presents a study on the long term effects of substance abuse in young adults and the effectiveness of PROSPER prevention interventions for young adolescents. Features participants from 28 rural communities in Pennsylvania and Iowa.
Author(s): Richard Spoth, Cleve Redmond, Chungyeol Shin, et al.
Citation: Psychological Medicine, 47(3), 2246-2259
Date: 10/2017
Type: Document
view details
Prescription Opioid Misuse among Rural Community Pharmacy Patients: Pilot Study for Screening and Implications for Future Practice and Research
Examines rural and urban community pharmacy patients in Pennsylvania to describe and compare patterns of opioid medication misuse. Identifies demographic and risk factors associated with rural and urban opioid medication misuse. Includes demographic statistics by rural and urban areas, such as education, employment status, and misuse behaviors. Offers recommendations to address opioid medication misuse.
Author(s): Gerald T. Cochran, Rafael J. Engel, Valerie J. Hruschak, Ralph E. Tarter
Citation: Journal of Pharmacy Practice, 30(5), 498-505
Date: 10/2017
Type: Document
view details
Examines rural and urban community pharmacy patients in Pennsylvania to describe and compare patterns of opioid medication misuse. Identifies demographic and risk factors associated with rural and urban opioid medication misuse. Includes demographic statistics by rural and urban areas, such as education, employment status, and misuse behaviors. Offers recommendations to address opioid medication misuse.
Author(s): Gerald T. Cochran, Rafael J. Engel, Valerie J. Hruschak, Ralph E. Tarter
Citation: Journal of Pharmacy Practice, 30(5), 498-505
Date: 10/2017
Type: Document
view details
The Opioid Epidemic and Federal Efforts to Address It: Frequently Asked Questions
Provides an overview of America's opioid problem, including information on abuse and supply, and discusses federal agencies and programs that address opioid abuse. Also discusses recent federal legislation and state-level policies that seek to combat the opioid problem.
Date: 10/2017
Type: Document
Sponsoring organization: Congressional Research Service
view details
Provides an overview of America's opioid problem, including information on abuse and supply, and discusses federal agencies and programs that address opioid abuse. Also discusses recent federal legislation and state-level policies that seek to combat the opioid problem.
Date: 10/2017
Type: Document
Sponsoring organization: Congressional Research Service
view details
Preventing Drug Abuse: Low Participation by Pharmacies and Other Entities as Voluntary Collectors of Unused Prescription Drugs
Report to Congress documenting low participation rates among pharmacies and other eligible entities in the Drug Enforcement Administration's (DEA) unused controlled substance collection and disposal program. Includes an outline of program requirements, a state-by-state overview of currently eligible and enrolled entities, and information about participation rates by rural and urban location.
Additional links: Full Report
Date: 10/2017
Type: Document
Sponsoring organization: Government Accountability Office
view details
Report to Congress documenting low participation rates among pharmacies and other eligible entities in the Drug Enforcement Administration's (DEA) unused controlled substance collection and disposal program. Includes an outline of program requirements, a state-by-state overview of currently eligible and enrolled entities, and information about participation rates by rural and urban location.
Additional links: Full Report
Date: 10/2017
Type: Document
Sponsoring organization: Government Accountability Office
view details
Opioid Use Disorders: HHS Needs Measures to Assess the Effectiveness of Efforts to Expand Access to Medication-Assisted Treatment
Reviews U.S. Department of Health and Human Services' (HHS) efforts to expand access to and the use of medication assisted treatment (MAT) for treating opioid use disorders. Includes a discussion of rural-specific programs and makes recommendations for improving future efforts and overall program evaluation.
Additional links: Full Report
Date: 10/2017
Type: Document
Sponsoring organization: Government Accountability Office
view details
Reviews U.S. Department of Health and Human Services' (HHS) efforts to expand access to and the use of medication assisted treatment (MAT) for treating opioid use disorders. Includes a discussion of rural-specific programs and makes recommendations for improving future efforts and overall program evaluation.
Additional links: Full Report
Date: 10/2017
Type: Document
Sponsoring organization: Government Accountability Office
view details
Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas — United States
Reports on trends in illicit drug use, illicit drug use disorders, and overdose deaths in large metropolitan, small metropolitan, and nonmetropolitan areas, based on 2003–2014 National Survey on Drug Use and Health (NSDUH) data and 1999–2015 National Vital Statistics System Mortality (NVSS-M) data. Includes metro/nonmetro illicit drug use data by sex, age group, race/ethnicity, and household income. Includes data on metro/nonmetro drug overdose deaths by sex, race/ethnicity, intent (unintentional, homicide, suicide, undetermined), and age group.
Author(s): Karin A. Mack, Christopher M. Jones, Michael F. Ballesteros
Citation: MMWR Surveillance Summaries, 66(19), 1-12
Date: 10/2017
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
Reports on trends in illicit drug use, illicit drug use disorders, and overdose deaths in large metropolitan, small metropolitan, and nonmetropolitan areas, based on 2003–2014 National Survey on Drug Use and Health (NSDUH) data and 1999–2015 National Vital Statistics System Mortality (NVSS-M) data. Includes metro/nonmetro illicit drug use data by sex, age group, race/ethnicity, and household income. Includes data on metro/nonmetro drug overdose deaths by sex, race/ethnicity, intent (unintentional, homicide, suicide, undetermined), and age group.
Author(s): Karin A. Mack, Christopher M. Jones, Michael F. Ballesteros
Citation: MMWR Surveillance Summaries, 66(19), 1-12
Date: 10/2017
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
Implementing Medication-Assisted Treatment for Opioid Use Disorder in Rural Primary Care: Environmental Scan Volume 1
Details challenges and barriers to implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in a primary care setting, such as healthcare policy, workforce, and financing, among others. Includes 250 tools and resources to help overcome barriers and support implementation MAT in rural areas.
Additional links: Volume 2: Tools and Resources
Author(s): Garrett E. Moran, Caroline M. Snyder, Rebecca F. Noftsinger, Joshua K. Noda
Date: 10/2017
Type: Document
Sponsoring organization: Agency for Healthcare Research and Quality
view details
Details challenges and barriers to implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in a primary care setting, such as healthcare policy, workforce, and financing, among others. Includes 250 tools and resources to help overcome barriers and support implementation MAT in rural areas.
Additional links: Volume 2: Tools and Resources
Author(s): Garrett E. Moran, Caroline M. Snyder, Rebecca F. Noftsinger, Joshua K. Noda
Date: 10/2017
Type: Document
Sponsoring organization: Agency for Healthcare Research and Quality
view details
The Federal Response to the Opioid Crisis
Presents the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) hearing on the government's response on the opioid crisis. Includes testimonies from SAMHSA, CDC, NIH, and the FDA regarding current efforts to increase access to treatment for opioid addiction and promote preventative measures across the U.S.
Additional links: Written Testimony
Date: 10/2017
Type: Video/Multimedia
Sponsoring organization: Senate Committee on Health, Education, Labor & Pensions
view details
Presents the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) hearing on the government's response on the opioid crisis. Includes testimonies from SAMHSA, CDC, NIH, and the FDA regarding current efforts to increase access to treatment for opioid addiction and promote preventative measures across the U.S.
Additional links: Written Testimony
Date: 10/2017
Type: Video/Multimedia
Sponsoring organization: Senate Committee on Health, Education, Labor & Pensions
view details
Exploring Rural Disparities in Medical Diagnoses among Veterans with Transgender-related Diagnoses Utilizing Veterans Health Administration Care
Presents a study on the differences in transgender-related diagnoses of veterans treated by the Veterans Health Administration in rural versus urban areas. Discusses medical conditions associated with transgender veterans, such as substance use and post-traumatic stress disorder, among others.
Author(s): Leigh A. Bukowski, John Blosnich, Jillian C. Shipherd, et al.
Citation: Medical Care, 55(9 Suppl2), S97-S103
Date: 09/2017
Type: Document
view details
Presents a study on the differences in transgender-related diagnoses of veterans treated by the Veterans Health Administration in rural versus urban areas. Discusses medical conditions associated with transgender veterans, such as substance use and post-traumatic stress disorder, among others.
Author(s): Leigh A. Bukowski, John Blosnich, Jillian C. Shipherd, et al.
Citation: Medical Care, 55(9 Suppl2), S97-S103
Date: 09/2017
Type: Document
view details
Using Telehealth to Identify and Manage Mental Health and Substance Use Disorder Conditions in Rural Areas
Reports on an environmental scan, discussions with providers and stakeholders, and site visits regarding how telehealth supports behavioral health and substance use disorder treatment. Addresses how telehealth is used, implementation, services offered, financing and sustainability. Focuses on the implications for treating opioid use disorders in rural areas, in particular, using medication-assisted treatment (MAT) with support from telehealth. Appendix B includes site briefs from the 9 states included in the study.
Date: 09/2017
Type: Document
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Reports on an environmental scan, discussions with providers and stakeholders, and site visits regarding how telehealth supports behavioral health and substance use disorder treatment. Addresses how telehealth is used, implementation, services offered, financing and sustainability. Focuses on the implications for treating opioid use disorders in rural areas, in particular, using medication-assisted treatment (MAT) with support from telehealth. Appendix B includes site briefs from the 9 states included in the study.
Date: 09/2017
Type: Document
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details